Epigenetic alterations underlying autoimmune diseases

Autoimmunity

Volumn 49, Issue 2, 2016, Pages 69-83

  Aslani, Saeed ^a   Mahmoudi, Mahdi ^b,c   Karami, Jafar ^a   Jamshidi, Ahmad Reza ^b   Malekshahi, Zahra ^a   Nicknam, Mohammad Hossein ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autoimmune disease; DNA methylation; environment; epigenetics; histone acetylation

Indexed keywords

DNA; HISTONE; MICRORNA;

ANKYLOSING SPONDYLITIS; AUTOIMMUNE DISEASE; DNA METHYLATION; EPIGENETICS; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; ACETYLATION; AUTOIMMUNE DISEASES; ENVIRONMENT; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; IMMUNOLOGY; METABOLISM; METHYLATION;

ACETYLATION; AUTOIMMUNE DISEASES; DNA METHYLATION; ENVIRONMENT; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HISTONES; HUMANS; METHYLATION; MICRORNAS;

EID: 84954228759     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2015.1134511     Document Type: Review

References (191)

1. Waddington, C. H. 1942. Canalization of development and the inheritance of acquired characters. Nature 150: 563-565
2. Grolleau-Julius, A., D. Ray, and, R. L. Yung,. 2010. The role of epigenetics in aging and autoimmunity. Clinical Rev. Allergy Immunol. 39: 42-50
3. Brooks, W. H. 2010. X chromosome inactivation and autoimmunity. Clin. Rev. Allergy Immunol. 39: 20-29
4. Selmi, C., Q. Lu, and, M. C. Humble,. 2012. Heritability versus the role of the environment in autoimmunity. J. Autoimmun. 39: 249-252
5. Miller, F. W., K. M. Pollard, C. G. Parks, et al. 2012. Criteria for environmentally associated autoimmune diseases. J. Autoimmun. 39: 253-258
6. Ngalamika, O., Y. Zhang, H. Yin, et al. 2012. Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review. J. Autoimmun. 39: 451-465
7. Hedrich, C. M. 2011. Genetic variation and epigenetic patterns in autoimmunity. J. Genet. Syndr. Gene Ther. 2: 0e2. DOI: 10.4172/2157-7412.10000e2
8. Iqbal, K., S. G. Jin, G. P. Pfeifer, and, P. E. Szabo,. 2011. Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc. Natl. Acad. Sci. USA 108: 3642-3647
9. Wossidlo, M., T. Nakamura, K. Lepikhov, et al. 2011. 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat. Commun. 2: 233-241
10. Meda, F., M. Folci, A. Baccarelli, and, C. Selmi,. 2011. The epigenetics of autoimmunity. Cell. Mol. Immunol. 8: 226-236
11. Greer, J. M., and, P. A. McCombe,. 2012. The role of epigenetic mechanisms and processes in autoimmune disorders. Biol.: Targets Therapy 6: 307-327
12. Jaenisch, R., and, A. Bird,. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33: 245-254
13. Lister, R., M. Pelizzola, R. H. Dowen, et al. 2009. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462: 315-322
14. Gardiner-Garden, M., and, M. Frommer,. 1987. CpG islands in vertebrate genomes. J. Mol. Biol. 196: 261-282
15. Gupta, S., S. Y. Kim, S. Artis D., et al. 2010. Histone methylation regulates memory formation. J. Neurosci.: Offic. J. Soc. Neurosci. 30: 3589-3599
16. Zhang, Y., and, D. Reinberg,. 2001. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev. 15: 2343-2360
17. Wood, A., and, A. Shilatifard,. 2004. Posttranslational modifications of histones by methylation. Adv. Protein Chem. 67: 201-222
18. Sawan, C., and, Z. Herceg,. 2010. Histone modifications and cancer. Adv. Genet. 70: 57-85
19. Feng, Q., H. Wang, H. H. Ng, et al. 2002. Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain. Curr. Biol.: CB 12: 1052-1058
20. Ng, H. H., Q. Feng, H. Wang, et al. 2002. Lysine methylation within the globular domain of histone H3 by Dot1 is important for telomeric silencing and Sir protein association. Genes Dev. 16: 1518-1527
21. Branscombe, T. L., A. Frankel, J. H. Lee, et al. 2001. PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. J. Biol. Chem. 276: 32971-32976
22. Weiss, V. H., A. E. McBride, M. A. Soriano, et al. 2000. The structure and oligomerization of the yeast arginine methyltransferase, Hmt1. Nat. Struct. Biol. 7: 1165-1171
23. Zhang, X., L. Zhou, and, X. Cheng,. 2000. Crystal structure of the conserved core of protein arginine methyltransferase PRMT3. EMBO J. 19: 3509-3519
24. Kouzarides, T. 2007. Chromatin modifications and their function. Cell 128: 693-705
25. Glozak, M. A., N. Sengupta, X. Zhang, and, E. Seto,. 2005. Acetylation and deacetylation of non-histone proteins. Gene 363: 15-23
26. Shahbazian, M. D., and, M. Grunstein,. 2007. Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem. 76: 75-100
27. Grunstein, M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389: 349-352
28. Kuo, M. H., and, C. D. Allis,. 1998. Roles of histone acetyltransferases and deacetylases in gene regulation. BioEssays: News Rev. Mol. Cell. Dev. Biol. 20: 615-626
29. Gallinari, P., S. Di Marco, P. Jones, et al. 2007. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Res. 17: 195-211
30. De Ruijter, A., A. Van Gennip, H. Caron, et al. 2003. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370: 737-749
31. Struhl, K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12: 599-606
32. Turner, B. M. 2000. Histone acetylation and an epigenetic code. BioEssays: News Rev. Mol. Cell. Dev. Biol. 22: 836-845
33. Rodriguez, A., S. Griffiths-Jones, J. L. Ashurst, and, A. Bradley,. 2004. Identification of mammalian microRNA host genes and transcription units. Genome Res. 14: 1902-1910
34. Lee, Y., M. Kim, J. Han, et al. 2004. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23: 4051-4060
35. Cai, X., C. H. Hagedorn, and, B. R. Cullen,. 2004. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA (New York, N.Y.) 10: 1957-1966
36. Gregory, R. I., T. P. Chendrimada, and, R. Shiekhattar,. 2006. MicroRNA biogenesis: isolation and characterization of the microprocessor complex. Methods Mol. Biol. (Clifton, N.J.) 342: 33-47
37. Berezikov, E., W. J. Chung, J. Willis, E., et al. 2007. Mammalian mirtron genes. Mol. Cell. 28: 328-336
38. Murchison, E. P., and, G. J. Hannon,. 2004. miRNAs on the move: miRNA biogenesis and the RNAi machinery. Curr. Opin. Cell Biol. 16: 223-229
39. Lund, E., and, J. E. Dahlberg,. 2006. Substrate selectivity of exportin 5 and Dicer in the biogenesis of microRNAs. Cold Spring Harbor Symp. Quant. Biol. 71: 59-66
40. Ji, X. 2008. The mechanism of RNase III action: how dicer dices. Curr. Top. Microbiol. Immunol. 320: 99-116
41. Rana, T. M. 2007. Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol. 8: 23-36
42. Pratt, A. J., and, I. J. MacRae,. 2009. The RNA-induced silencing complex: a versatile gene-silencing machine. J. Biol. Chem. 284: 17897-17901
43. Jing, Q., S. Huang, S. Guth, et al. 2005. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120: 623-634
44. Kawasaki, H., and, K. Taira,. 2004. MicroRNA-196 inhibits HOXB8 expression in myeloid differentiation of HL60 cells. Nucl. Acids Symp. Series (Oxf.). (2004): 211-212
45. Eulalio, A., E. Huntzinger, T. Nishihara, et al. 2009. Deadenylation is a widespread effect of miRNA regulation. RNA (New York, N.Y.) 15: 21-32
46. Bazzini, A. A., M. T. Lee, and, A. J. Giraldez,. 2012. Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish. Science (New York, N.Y.) 336: 233-237
47. Djuranovic, S., A. Nahvi, and, R. Green,. 2012. miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science (New York, N.Y.) 336: 237-240
48. Arnett, F. C., S. M. Edworthy, D. A. Bloch, et al. (1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheumat. 31: 315-324
49. Klein, K., and, S. Gay,. 2013. Epigenetic modifications in rheumatoid arthritis, a review. Curr. Opin. Pharmacol. 13: 420-425
50. Karouzakis, E., R. E. Gay, B. A. Michel, et al. 2009. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheumat. 60: 3613-3622
51. Neidhart, M., J. Rethage, S. Kuchen, et al. 2000. Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheumat. 43: 2634-2647
52. Takami, N., K. Osawa, Y. Miura, et al. 2006. Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthritis Rheumat. 54: 779-787
53. Nile, C. J., R. C. Read, M. Akil, et al. 2008. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheumat. 58: 2686-2693
54. Liao, J., G. Liang, S. Xie, et al. 2012. CD40L demethylation in CD4+ T cells from women with rheumatoid arthritis. Clin. Immunol. 145: 13-18
55. Manabe, H., Y. Nasu, T. Komiyama, et al. 2008. Inhibition of histone deacetylase down-regulates the expression of hypoxia-induced vascular endothelial growth factor by rheumatoid synovial fibroblasts. Inflamm. Res. 57: 4-10
56. Nishida, K., T. Komiyama, S. i. Miyazawa, et al. 2004. Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21WAF1/Cip1 expression. Arthritis Rheumat. 50: 3365-3376
57. Stanczyk, J., D. M. L. Pedrioli, F. Brentano, et al. 2008. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheumat. 58: 1001-1009
58. Nakasa, T., S. Miyaki, A. Okubo, et al. 2008. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheumat. 58: 1284-1292
59. Fulci, V., G. Scappucci, G. D. Sebastiani, et al. 2010. miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Human Immunol. 71: 206-211
60. Stanczyk, J., C. Ospelt, E. Karouzakis, et al. 2011. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheumat. 63: 373-381
61. Lu, Q. 2013. The critical importance of epigenetics in autoimmunity. J. Autoimmun. 41: 1-5
62. Lei, W., Y. Luo, W. Lei, et al. 2009. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand. J. Rheumatol. 38: 369-374
63. Lu, Q., A. Wu, L. Tesmer, et al. 2007. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 179: 6352-6358
64. Zhou, Y., J. Yuan, Y. Pan, et al. 2009. T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin. Immunol. 132: 362-370
65. Barreto, G., A. Schäfer, J. Marhold, et al. 2007. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 445: 671-675
66. Li, Y., M. Zhao, H. Yin, et al. 2010. Overexpression of the growth arrest and DNA damage-induced 45α gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells. Arthritis Rheumat. 62: 1438-1447
67. Li, Y., C. Huang, M. Zhao, et al. 2013. A possible role of HMGB1 in DNA demethylation in CD4. Clin. Dev. Immunol. 2013: Article number 206298. DOI: 10.1155/2013/206298
68. Luo, Y., M. Zhao, and, Q. Lu,. 2010. Demethylation of promoter regulatory elements contributes to CD70 overexpression in CD4+ T cells from patients with subacute cutaneous lupus erythematosus. Clin. Exp. Dermatol. 35: 425-430
69. Zhao, M., Y. Sun, F. Gao, et al. 2010. Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. J. Autoimmun. 35: 58-69
70. Dean, G. S., J. Tyrrell-Price, E. Crawley, and, D. A. Isenberg,. 2000. Cytokines and systemic lupus erythematosus. Ann. Rheum. Dis. 59: 243-251
71. Zhao, M., J. Tang, F. Gao, et al. 2010. Hypomethylation of IL-10 and IL-13 promoters in CD4+ T cells of patients with SLE. J. Biomed. Biotechnol. 2010: 9310-9318
72. Zhao, M., S. Liu, S. Luo, et al. 2014. DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype. J. Autoimmun. 54: 127-136
73. Hu, N., X. Qiu, Y. Luo, et al. 2008. Abnormal histone modification patterns in lupus CD4+ T cells. J. Rheumatol. 35: 804-810
74. Hu, N., H. Long, M. Zhao, et al. 2009. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice. Scand. J. Rheumatol. 38: 464-471
75. Long, H., W. Huang, H. Yin, et al. 2009. Abnormal expression pattern of histone demethylases in CD4+ T cells of MRL/lpr lupus-like mice. Lupus 18: 1327-1328
76. Zhao, M., X. Wu, Q. Zhang, et al. 2010. RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1. Arthritis Res. Therapy 12: R227
77. Zhou, Y., X. Qiu, Y. Luo, et al. 2011. Histone modifications and methyl-CpG-binding domain protein levels at the TNFSF7 (CD70) promoter in SLE CD4+ T cells. Lupus 20: 1365-1371
78. Zhang, Q., J. Liao, M. Zhao, et al. 2011. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus. J. Autoimmun. 37: 180-189
79. Liu, Y., J. Liao, M. Zhao, et al. 2015. Increased expression of TLR2 in CD4+ T cells from SLE patients enhances immune reactivity and promotes IL-17 expression through histone modifications. Eur. J. Immunol. 45: 2683-2693
80. Hedrich, C. M., and, G. C. Tsokos,. 2011. Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. Trends Mol. Med. 17: 714-724
81. Pan, Y., and, A. H. Sawalha,. 2009. Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. Transl. Res.: J. Lab. Clin. Med. 153: 4-10
82. Zhao, S., Y. Wang, Y. Liang, et al. 2011. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheumat. 63: 1376-1386
83. Ding, S., Y. Liang, M. Zhao, et al. 2012. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheumat. 64: 2953-2963
84. Luo, S., Y. Liu, G. Liang, et al. 2015. The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus. Clin. Epigenet. 7: 24. DOI: 10.1186/s13148-015-0063-7
85. Varga, J., and, D. Abraham,. 2007. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J. Clin. Invest. 117: 557-567
86. Lian, X., R. Xiao, X. Hu, et al. 2012. DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility. Arthritis Rheumat. 64: 2338-2345
87. Jiang, H., R. Xiao, X. Lian, et al. 2012. Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis. Clin. Immunol. 143: 39-44
88. Wang, Y., Y. Shu, Y. Xiao, et al. 2014. Hypomethylation and overexpression of ITGAL (CD11a) in CD4 T cells in systemic sclerosis. Clin. Epigenet. 6: 25. DOI: 10.1186/1868-7083-6-25
89. Czuwara-Ladykowska, J., F. Shirasaki, P. Jackers, et al. 2001. Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J. Biol. Chem. 276: 20839-20848
90. Wang, Y., P. S. Fan, and, B. Kahaleh,. 2006. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheumat. 54: 2271-2279
91. Luo, Y., Y. Wang, Q. Wang, et al. 2013. Systemic sclerosis: genetics and epigenetics. J. Autoimmun. 41: 161-167
92. Wang, Y., Y. Yang, Y. Luo, et al. 2013. Aberrant histone modification in peripheral blood B cells from patients with systemic sclerosis. Clin. Immunol. 149: 46-54
93. Krämer, M., C. Dees, J. Huang, et al. 2013. Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis. Ann. Rheumat. Dis. 72: 614-620
94. Wang, Q., Y. Xiao, Y. Shi, et al. 2015. Overexpression of JMJD3 may contribute to demethylation of H3K27me3 in CD4+ T cells from patients with systemic sclerosis. Clin. Immunol. (Orlando, FL) 161: 396-399
95. Broen, J. C., T. R. Radstake, and, M. Rossato,. 2014. The role of genetics and epigenetics in the pathogenesis of systemic sclerosis. Nat. Rev. Rheumatol. 10: 671-681
96. Makino, K., M. Jinnin, I. Kajihara, et al. 2012. Circulating miR-142-3p levels in patients with systemic sclerosis. Clin. Exp. Dermatol. 37: 34-39
97. Dougados, M., S. V. D. Linden, R. Juhlin, et al. 1991. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheumat. 34: 1218-1227
98. Khan, M., and, S. Van der Linden,. 1990. Ankylosing spondylitis and other spondyloarthropathies. Rheumat. Dis. Clin. N. Am. 16: 551-579
99. McHugh, K., and, P. Bowness,. 2012. The link between HLA-B27 and SpA-new ideas on an old problem. Rheumatology 51: 1529-1539
100. Colbert, R. A., M. L. DeLay, E. I. Klenk, and, G. Layh-Schmitt,. 2010. From HLA-B27 to spondyloarthritis: a journey through the ER. Immunol. Rev. 233: 181-202
101. Braun, J., and, J. Sieper,. 2007. Ankylosing spondylitis. Lancet 369: 1379-1390
102. Lai, N.-S., J.-L. Chou, G. C. Chen, et al. 2014. Association between cytokines and methylation of SOCS-1 in serum of patients with ankylosing spondylitis. Mol. Biol. Rep. 41: 3773-3780
103. Lai, N. S., H. C. Yu, H. C. Chen, et al. 2013. Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis. Clin. Exp. Immunol. 173: 47-57
104. Daoussis, D., and, A. P. Andonopoulos,. 2011. The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling? In Seminars in Arthritis and Rheumatism. Elsevier, New York. p. 170-177
105. Huang, J., G. Song, Z. Yin, et al. 2014. Elevated miR-29a expression is not correlated with disease activity index in PBMCs of patients with ankylosing spondylitis. Mod. Rheumatol. 24: 331-334
106. Sugatani, T., J. Vacher, and, K. A. Hruska,. 2011. A microRNA expression signature of osteoclastogenesis. Blood 117: 3648-3657
107. Huang, C.-H., J. C.-C. Wei, W.-C. Chang, et al. 2014. Higher expression of whole blood microRNA-21 in patients with ankylosing spondylitis associated with programmed cell death 4 mRNA expression and collagen cross-linked C-telopeptide concentration. J. Rheumatol. 41: 1104-1111
108. Fox, R. I. 2005. Sjögren's syndrome. Lancet 366: 321-331
109. González, S., S. Aguilera, C. Alliende, et al. 2011. Alterations in type I hemidesmosome components suggestive of epigenetic control in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheumat. 63: 1106-1115
110. Yin, H., M. Zhao, X. Wu, et al. 2010. Hypomethylation and overexpression of CD70 (TNFSF7) in CD4+ T cells of patients with primary Sjögren's syndrome. J. Dermatol. Sci. 59: 198-203
111. Pérez, P., J.-M. Anaya, S. Aguilera, et al. 2009. Gene expression and chromosomal location for susceptibility to Sjögren's syndrome. J. Autoimmun. 33: 99-108
112. Alevizos, I., and, G. G. Illei,. 2010. MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease. Autoimmun. Rev. 9: 618-621
113. Bulosan, M., K. M. Pauley, K. Yo, et al. 2009. Inflammatory caspases are critical for enhanced cell death in the target tissue of Sjögren's syndrome before disease onset. Immunol. Cell Biol. 87: 81-90
114. Loftus E. V. Jr. 2004. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126: 1504-1517
115. Gloria, L., M. Cravo, A. Pinto, et al. 1996. DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis. Cancer 78: 2300-2306
116. Hsieh, C.-J., B. Klump, K. Holzmann, et al. 1998. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res. 58: 3942-3945
117. Tahara, T., T. Shibata, M. Nakamura, et al. 2009. Effect of MDR1 gene promoter methylation in patients with ulcerative colitis. Int. J. Mol. Med. 23: 521-527
118. Lin, Z., J. Hegarty, J. Cappel, et al. 2011. Identification of disease-associated DNA methylation in intestinal tissues from patients with inflammatory bowel disease. Clin. Genet. 80: 59-67
119. Cooke, J., H. Zhang, L. Greger, et al. 2012. Mucosal genome-wide methylation changes in inflammatory bowel disease. Inflamm. Bowel Dis. 18: 2128-2137
120. Saito, S., J. Kato, S. Hiraoka, et al. 2011. DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status. Inflamm. Bowel Dis. 17: 1955-1965
121. Bae, J.-H., J. Park, K. M. Yang, et al. 2014. Detection of DNA hypermethylation in sera of patients with Crohn's disease. Mol. Med. Rep. 9: 725-729
122. Takahashi, K., Y. Sugi, A. Hosono, and, S. Kaminogawa,. 2009. Epigenetic regulation of TLR4 gene expression in intestinal epithelial cells for the maintenance of intestinal homeostasis. J. Immunol. 183: 6522-6529
123. Vamadevan, A. S., M. Fukata, E. T. Arnold, et al. 2010. Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis. Innate Immun. 16: 93-103
124. Kellermayer, R., S. E. Dowd, R. A. Harris, et al. 2011. Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice. FASEB J. 25: 1449-1460
125. Takahashi, K., Y. Sugi, K. Nakano, et al. 2011. Epigenetic control of the host gene by commensal bacteria in large intestinal epithelial cells. J. Biol. Chem. 286: 35755-35762
126. Yin, L., and, W. O. Chung,. 2011. Epigenetic regulation of human β-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria. Mucosal Immunol. 4: 409-419
127. Olszak, T., D. An, S. Zeissig, et al. 2012. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336: 489-493
128. Wu, F., M. Zikusoka, A. Trindade, et al. 2008. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2α. Gastroenterology 135: 1624-1635. e1624
129. Wu, F., S. Zhang, T. Dassopoulos, et al. 2010. Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm. Bowel Dis. 16: 1729-1738
130. Gaspari, A. A. 2006. Innate and adaptive immunity and the pathophysiology of psoriasis. J. Am. Acad. Dermatol. 54: S67-S80
131. Lowes, M. A., A. M. Bowcock, and, J. G. Krueger,. 2007. Pathogenesis and therapy of psoriasis. Nature 445: 866-873
132. Zhang, P., Y. Su, H. Chen, et al. 2010. Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris. J. Dermatol. Sci. 60: 40-42
133. Zhang, K., R. Zhang, X. Li, et al. 2009. Promoter methylation status of p15 and p21 genes in HPP-CFCs of bone marrow of patients with psoriasis. Eur. J. Dermatol. 19: 141-146
134. Chen, M., Z. Q. Chen, P. G. Cui, et al. 2008. The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance. Br. J. Dermatol. 158: 987-993
135. Ruchusatsawat, K., J. Wongpiyabovorn, S. Shuangshoti, et al. 2006. SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis. J. Mol. Med. 84: 175-182
136. Zhang, P., Y. Su, M. Zhao, et al. 2011. Abnormal histone modifications in PBMCs from patients with psoriasis vulgaris. Eur. J. Dermatol. 21: 552-557
137. Blander, G., A. Bhimavarapu, T. Mammone, et al. 2009. SIRT1 promotes differentiation of normal human keratinocytes. J. Invest. Dermatol. 129: 41-49
138. Tovar-Castillo, L. E., J. C. Cancino-Díaz, F. García-Vázquez, et al. 2007. Under-expression of VHL and over-expression of HDAC-1, HIF-1α, LL-37, and IAP-2 in affected skin biopsies of patients with psoriasis. Int. J. Dermatol. 46: 239-246
139. Sonkoly, E., T. Wei, P. C. Janson, et al. 2007. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One 2: e610
140. Kubo, M., T. Hanada, and, A. Yoshimura,. 2003. Suppressors of cytokine signaling and immunity. Nat. Immunol. 4: 1169-1176
141. Xu, N., F. Meisgen, L. M. Butler, et al. 2013. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J. Immunol. 190: 678-688
142. Boldin, M., and, K. Chang,. 2006. NF-kappaB· dependent induction of microRNA miR 146. An inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103: 12481-12486
143. Tili, E., J.-J. Michaille, A. Cimino, et al. 2007. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-α stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 179: 5082-5089
144. Zibert, J. R., M. B. Løvendorf, T. Litman, et al. 2010. MicroRNAs and potential target interactions in psoriasis. J. Dermatol. Sci. 58: 177-185
145. Zhao, M., L.-t. Wang, G.-p. Liang, et al. 2014. Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4+ T cells of psoriasis vulgaris. Clin. Immunol. 150: 22-30
146. Eizirik, D. L., M. L. Colli, and, F. Ortis,. 2009. The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat. Rev. Endocrinol. 5: 219-226
147. Barrett, J. C., D. G. Clayton, P. Concannon, et al. 2009. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 41: 703-707
148. Cooper, J. D., D. J. Smyth, A. M. Smiles, et al. 2008. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat. Genet. 40: 1399-1401
149. Knip, M., R. Veijola, S. M. Virtanen, et al. 2005. Environmental triggers and determinants of type 1 diabetes. Diabetes 54: S125-S136
150. Lefebvre, D. E., K. L. Powell, A. Strom, and, F. W. Scott,. 2006. Dietary proteins as environmental modifiers of type 1 diabetes mellitus. Annu. Rev. Nutr. 26: 175-202
151. Kauri, L. M., G.-S. Wang, C. Patrick, et al. 2007. Increased islet neogenesis without increased islet mass precedes autoimmune attack in diabetes-prone rats. Lab. Invest. 87: 1240-1251
152. Wang, Z., C. Zang, J. A. Rosenfeld, et al. 2008. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat. Genet. 40: 897-903
153. Akirav, E. M., J. Lebastchi, E. M. Galvan, et al. 2011. Detection of β cell death in diabetes using differentially methylated circulating DNA. Proc. Natl. Acad. Sci. 108: 19018-19023
154. Pfleger, C., G. Meierhoff, H. Kolb, et al. 2010. Association of T-cell reactivity with β-cell function in recent onset type 1 diabetes patients. J. Autoimmun. 34: 127-135
155. Miao, F., D. D. Smith, L. Zhang, et al. 2008. Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation an epigenetic study in diabetes. Diabetes 57: 3189-3198
156. Sebastiani, G., F. A. Grieco, I. Spagnuolo, et al. 2011. Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity. Diabetes/Metabol. Res. Rev. 27: 862-866
157. Hezova, R., O. Slaby, P. Faltejskova, et al. 2010. microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cell. Immunol. 260: 70-74
158. Salas-Pérez, F., E. Codner, E. Valencia, et al. 2013. MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes. Immunobiology 218: 733-737
159. Hirschfield, G. M., and, M. E. Gershwin,. 2013. The immunobiology and pathophysiology of primary biliary cirrhosis. Annu. Rev. Pathol.: Mech. Dis. 8: 303-330
160. Poupon, R. 2010. Primary biliary cirrhosis: a 2010 update. J. Hepatol. 52: 745-758
161. Selmi, C., F. Cavaciocchi, A. Lleo, et al. 2014. Corrigendum: Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis. Front. Immunol. 5: 371. DOI: 10.3389/fimmu.2014.0037
162. Mitchell, M. M., A. Lleo, L. Zammataro, et al. 2011. Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis. Epigenetics 6: 95-102
163. Carrel, L., and, H. F. Willard,. 2005. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434: 400-404
164. Lleo, A., J. Liao, P. Invernizzi, et al. 2012. Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology 55: 153-160
165. Mayo, M. J., J. M. Mosby, R. Jeyarajah, et al. 2006. The relationship between hepatic immunoglobulin production and CD154 expression in chronic liver diseases. Liver Int. 26: 187-196
166. Lefkowitz, R. J., and, S. K. Shenoy,. 2005. Transduction of receptor signals by β-arrestins. Science 308: 512-517
167. Shi, Y., Y. Feng, J. Kang, et al. 2007. Critical regulation of CD4+ T cell survival and autoimmunity by β-arrestin 1. Nat. Immunol. 8: 817-824
168. Hu, Z., Y. Huang, Y. Liu, et al. 2011. β-Arrestin 1 modulates functions of autoimmune T cells from primary biliary cirrhosis patients. J. Clin. Immunol. 31: 346-355
169. van Steensel, B. 2005. Mapping of genetic and epigenetic regulatory networks using microarrays. Nat. Genet. 37: S18-S24
170. Cedar, H., and, Y. Bergman,. 2009. Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 10: 295-304
171. Laird, P. W. 2010. Principles and challenges of genome-wide DNA methylation analysis. Nat. Rev. Genet. 11: 191-203
172. Jirtle, R. L., and, M. K. Skinner,. 2007. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 8: 253-262
173. Esteller, M. 2007. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 8: 286-298
174. Brooks, W. H., C. Le Dantec, J.-O. Pers, et al. 2010. Epigenetics and autoimmunity. J. Autoimmun. 34: J207-J219
175. Cang, S., Q. Lu, Y. Ma, and, D. Liu,. 2010. Clinical advances in hypomethylating agents targeting epigenetic pathways. Curr. Cancer Drug Targets 10: 539-545
176. Tan, J., S. Cang, Y. Ma, et al. 2010. Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J. Hematol. Oncol. 3: 1-13
177. Quintero-Ronderos, P., and, G. Montoya-Ortiz,. 2012. Epigenetics and autoimmune diseases. Autoimm. Dis. 2012: Article number 593720. DOI: 10.1155/2012/593720
178. Qu, B., and, N. Shen,. 2015. miRNAs in the pathogenesis of systemic lupus erythematosus. Int. J. Mol. Sci. 16: 9557-9572
179. Zhu, H., Y. Li, S. Qu, et al. 2012. MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma. J. Clin. Immunol. 32: 514-522
180. Altorok, N., P. Coit, T. Hughes, et al. 2014. Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren's syndrome. Arthritis Rheumatol. 66: 731-739
181. Harris, R. A., D. Nagy-Szakal, N. Pedersen, et al. 2012. Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases. Inflamm. Bowel Dis. 18: 2334-2341
182. Lin, Z., J. P. Hegarty, W. Yu, et al. 2012. Identification of disease-associated DNA methylation in B cells from Crohns disease and ulcerative colitis patients. Digest. Dis. Sci. 57: 3145-3153
183. Nimmo, E. R., J. G. Prendergast, M. C. Aldhous, et al. 2012. Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway. Inflamm. Bowel Dis. 18: 889-899
184. Kim, S. W., E. S. Kim, C. M. Moon, et al. 2012. Abnormal genetic and epigenetic changes in signal transducer and activator of transcription 4 in the pathogenesis of inflammatory bowel diseases. Digest. Dis. Sci. 57: 2600-2607
185. Häsler, R., Z. Feng, L. Bäckdahl, et al. 2012. A functional methylome map of ulcerative colitis. Genome Res. 22: 2130-2137
186. Tsaprouni, L. G., K. Ito, J. J. Powell, et al. 2011. Differential patterns of histone acetylation in inflammatory bowel diseases. J. Inflamm. (Lond.) 8: 1-1
187. Wu, F., N. J. Guo, H. Tian, et al. 2011. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm. Bowel Dis. 17: 241-250
188. Selmi, C., M. J. Mayo, N. Bach, et al. 2004. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 127: 485-492
189. Alberici, F., D. Martorana, and, A. Vaglio,. 2014. Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol. Dial. Transpl. 30: i37-45
190. Coit, P., M. Jeffries, N. Altorok, et al. 2013. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients. J. Autoimmun. 43: 78-84
191. Lee, J. C., and, K. G. Smith,. 2014. Prognosis in autoimmune and infectious disease: new insights from genetics. Clin. Transl. Immunol. 3: e15